| Literature DB >> 19951442 |
Ji A Seo1, Byoung Gwon Kim, Hyunjoo Cho, Hye Sook Kim, Juri Park, Sei Hyun Baik, Dong Seop Choi, Moon Ho Park, Sangmee Ahn Jo, Young Ho Koh, Changsu Han, Nan Hee Kim.
Abstract
BACKGROUND: In Korea, the cutoff values of waist circumference (WC) for the identification of metabolic syndrome (MetS) were suggested to be 90 cm for men and 85 cm for women based on the analysis mainly in middle-aged adults. As aging is associated with increased fat, especially abdominal visceral fat, the cutoff value of WC may differ according to age. In addition, the usefulness of visceral abdominal fat area (VFA) to predict MetS in the elderly has not been studied yet. We aimed to suggest WC and VFA criteria and to compare the predictability of WC and VFA to identify people at risk for MetS.Entities:
Mesh:
Year: 2009 PMID: 19951442 PMCID: PMC2797519 DOI: 10.1186/1471-2458-9-443
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Characteristics of study subjects according to the presence of two or more metabolic risk factors except WC in elderly Koreans
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Total | Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC | Total | Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC | |||
| Absent | Present | Absent | Present | |||
| N (%) | 308 | 105 (34.1) | 203 (65.9) | 381 | 101 (26.5) | 280 (73.5) |
| Age (years) | 71.2 ± 5.2 | 70.6 ± 5.1 | 71.6 ± 5.3 | 70.5 ± 4.7 | 70.5 ± 5.0 | 70.5 ± 4.7 |
| Body mass index (kg/m2) | 24.0 ± 2.8 | 22.6 ± 2.4 | 24.7 ± 2.7* | 25.0 ± 3.1† | 23.4 ± 3.4 | 25.6 ± 2.8* |
| Waist circumference (cm) | 88.0 ± 7.6 | 83.9 ± 7.0 | 90.2 ± 7.0* | 88.5 ± 8.3 | 84.6 ± 9.1 | 90.0 ± 7.5* |
| VFA (cm2) | 103.6 ± 49.1 | 78.3 ± 40.4 | 116.7 ± 48.2* | 108.9 ± 45.4 | 84.0 ± 37.5 | 117.9 ± 44.7* |
| SFA (cm2) | 157.1 ± 50.9 | 138.6 ± 47.5 | 166.7 ± 50.1* | 239.4 ± 67.8† | 215.5 ± 74.9 | 248.0 ± 63.0* |
| Fasting glucose (mg/dl) | 96.5 ± 17.0 | 90.0 ± 8.9 | 99.8 ± 19.0* | 95.8 ± 21.1 | 88.1 ± 10.6 | 98.5 ± 23.1* |
| post 2 hr OGTT-glucose (mg/dl) | 129.5 ± 50.8 | 103.7 ± 34.0 | 145.5 ± 52.9* | 138.5 ± 51.7 | 109.1 ± 27.2 | 150.9 ± 54.5 |
| High glucose (n, (%))a | 151 (49.0) | 15 (14.3) | 136 (67.0)* | 187 (49.1) | 10 (9.9) | 177 (63.2)* |
| Taking oral hypoglycemic medication or insulin (n,(%)) | 41(13.3) | 3 (2.9) | 38 (18.7)* | 44 (13.6) | 3 (3.0) | 41 (14.6)* |
| Systolic blood pressure | 129.4 ± 15.6 | 123.2 ± 16.2 | 132.6 ± 14.3* | 127.3 ± 16.1 | 120.0 ± 13.4 | 129.9 ± 16.2* |
| Diastolic blood pressure | 76.1 ± 8.5 | 73.9 ± 7.5 | 77.3 ± 8.7* | 75.2 ± 8.0 | 72.1 ± 8.1 | 76.3 ± 7.7* |
| High blood pressure (n, (%))b | 205 (66.6) | 35 (33.3) | 170 (83.7)* | 249 (65.4) | 35 (34.7) | 214 (76.4)* |
| Taking antihypertensive medication (n, (%)) | 140(45.5) | 20 (19.1) | 120 (59.2)* | 185 (48.6) | 21 (20.8) | 164 (58.6)* |
| Triglycerides (mg/dl) | 137.1 ± 80.9 | 97.9 ± 29.3 | 157.4 ± 91.0* | 146.5 ± 80.9 | 92.2 ± 26.9 | 166.0 ± 84.9* |
| Hypertriglyceridemia (n, (%))c | 96 (31.2) | 5 (4.8) | 91 (44.8)* | 138 (36.2) | 1 (1.0) | 137 (48.9)* |
| HDL cholesterol (mg/dl) | 41.0 ± 10.2 | 46.8 ± 9.4 | 38.1 ± 9.2* | 43.1 ± 10.4† | 51.6 ± 9.8 | 40.0 ± 8.8* |
| Low HDL cholesterol (n,(%))d | 159 (51.6) | 16 (15.2) | 143 (70.4)* | 286 (75.1)† | 39 (38.6) | 247 (88.2)* |
| Taking lipid-lowering medication (n, (%)) | 31 (10.1) | 8 (7.6) | 23 (11.3) | 44 (11.6) | 10 (9.9) | 34 (12.1) |
Data are mean ± S.D. or %. VFA, Visceral abdominal fat area; SFA, Subcutaneous abdominal fat area
aHigh glucose was diagnosed if fasting glucose ≥100 mg/dl or post 2 hr OGTT-glucose ≥140 mg/dl or the subjects with oral hypoglycemic medication or insulin.
bHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects with antihypertensive medications.
cHypertriglyceridemia was diagnosed if triglycerides was ≥150 mg/dl in men and women.
dLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.
*: p <0.01 compared with subjects without two or more metabolic risk factors in each gender.
†: p < 0.01 compared with men.
Areas under the ROC curve of VFA, WC and BMI to identify the presence of the metabolic risk factors other than WC
| Men (n = 308) | Women (n = 381) | |||
|---|---|---|---|---|
| ROC curve area (95% CI) | ROC curve area (95% CI) | |||
| Two or more metabolic risk factors of the modified NCEP-ATP III criteria other than waist circumference | ||||
| VFA | 0.735 (0.676-0.794) | 0.715 (0.656-0.774) | ||
| WC | 0.750 (0.693-0.807) | 0.509 | 0.682 (0.617-0.747) | 0.229 |
| BMI | 0.717 (0.659-0.775) | 0.512 | 0.684 (0.619-0.749) | 0.270 |
| Fasting glucose ≥ 100 mg/dl or post 2 hr OGTT-glucose ≥ 140 mg/dl or medication for diabetes | ||||
| VFA | 0.670 (0.609-0.731) | 0.624 (0.568-0.680) | ||
| WC | 0.684 (0.624-0.744) | 0.431 | 0.612 (0.556-0.668) | 0.687 |
| BMI | 0.637 (0.575-0.699) | 0.283 | 0.581 (0.524-0.638) | 0.100 |
| High blood pressure a | ||||
| VFA | 0.653 (0.588-0.718) | 0.614 (0.554-0.674) | ||
| WC | 0.671 (0.609-0.733) | 0.445 | 0.608 (0.547-0.669) | 0.842 |
| BMI | 0.676 (0.613-0.739) | 0.397 | 0.617 (0.556-0.678) | 0.898 |
| Hypertriglyceridemia b | ||||
| VFA | 0.647 (0.585-0.709) | 0.673 (0.618-0.728) | ||
| WC | 0.622 (0.555-0.689) | 0.319 | 0.615 (0.558-0.672) | 0.028 |
| BMI | 0.600 (0.532-0.668) | 0.080 | 0.615 (0.559-0.671) | 0.032 |
| Low HDL cholesterol c | ||||
| VFA | 0.692 (0.633-0.751) | 0.620 (0.553-0.687) | ||
| WC | 0.664 (0.604-0.724) | 0.235 | 0.597 (0.526-0.668) | 0.431 |
| BMI | 0.631 (0.569-0.693) | 0.018 | 0.585 (0.514-0.656) | 0.229 |
VFA, visceral fat area; WC, waist circumference; BMI, body mass index
aHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects was receiving antihypertensive medications.
bHypertriglyceridemia was diagnosed if triglycerides was ≥ 150 mg/dl in men and women.
cLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.
Figure 1ROC curves to identify ≥2 metabolic risk factors other than WC. In both men and women, the AUC values for VFA did not show higher values compared to WC and BMI.
The optimal cutoff points of VFA, WC, and BMI to detect subjects with two or more metabolic risk factors except WC compared to various criteria
| Cut point | Sensitivity | Specificity | PPV | NPV | Distance | |||
|---|---|---|---|---|---|---|---|---|
| Men (n = 308) | ||||||||
| VFA(cm2) | Optimal cut point a | 92.6 | 70.4 | 70.5 | 82.2 | 44.8 | 0.41 | 0.42 |
| WC (cm) | Optimal cut point a | 86.5 | 74.9 | 65.7 | 80.9 | 42.5 | 0.41 | 0.43 |
| KOSSO's cut point b | 90.0 | 54.2 | 81.9 | 85.3 | 52.0 | 0.36 | 0.49 | |
| BMI (kg/m2) | Optimal cut point a | 23.7 | 63.1 | 70.5 | 80.5 | 50.3 | 0.34 | 0.47 |
| WHO's cut point c | 25.0 | 45.8 | 84.8 | 85.3 | 55.3 | 0.31 | 0.56 | |
| Women (n = 381) | ||||||||
| VFA (cm2) | Optimal cut point a | 88.9 | 72.5 | 59.4 | 83.2 | 56.2 | 0.32 | 0.49 |
| WC (cm) | Optimal cut point a | 86.5 | 69.3 | 60.4 | 82.9 | 58.5 | 0.30 | 0.50 |
| KOSSO's cut point b | 85.0 | 76.4 | 51.5 | 81.4 | 55.9 | 0.28 | 0.54 | |
| BMI (kg/m2) | Optimal cut point a | 23.9 | 72.5 | 58.4 | 82.9 | 56.6 | 0.31 | 0.50 |
| WHO's cut point c | 25.0 | 54.6 | 64.4 | 81.0 | 66.2 | 0.19 | 0.58 |
PPV, positive predictive value; NPV, negative predictive value
a : Optimal cut point from the present study for abdominal obesity
b: KOSSO's criteria for abdominal obesity [2]
c : WHO-Asia Pacific Region criteria for obesity [23]
Figure 2The proportion of subjects with abdominal obesity and metabolic syndrome using modified NCEP-ATP III criteria with KOSSO's WC cutoff points (≥ 90 cm for men and ≥ 85 cm for women) (A) or with our WC cutoff points (≥86.5 cm for both men and women) (B).